Pulling SEC filings + quote and writing the call…

NATIONAL BEVERAGE CORP
Next earnings Jul 1, 2026 (after close) · consensus $0.48 EPS, $302M rev
Last earnings +5.0% on 2026-07-02
Debt-free, 19.6% op-margin sparkling-water franchise growing 0.8% — quality compounder at a fair, not cheap, 16.9x P/E.
Revenue (FY2025) $1.20B · FY2025
Middling fundamentals and a rich price (~45% above fair value) leave little margin of safety — a wait-and-see.
National Beverage is a high-quality, owner-operated beverage business that screens better than its top-line suggests. FY2025 revenue grew just 0.8% to $1.20B, but the MD&A reveals the mix: a 1.7% increase in average selling price per case plus an extra 53rd selling week, offset by a 0.9% case-volume decline concentrated in the Power+ Brands (LaCroix, Rip It, juices) — the very portfolio management calls its strategic growth engine. That volume softness in the 'healthier refreshment' franchise is the central tension in this story; pricing and a calendar quirk are masking a flat-to-down underlying unit trend in a category (sparkling water) that now faces aggressive competition from Bubly, Waterloo, Liquid Death and Celsius.
What keeps this from being a sell is the quality of the underlying P&L and balance sheet. Gross margin expanded 100bps to 37.0% on lower packaging costs, operating margin reached 19.6% (operating income +7.8% to $235M), net income grew 5.7% to $187M and diluted EPS rose 5.3% to $1.99. The balance sheet is pristine: zero long-term debt, $194M cash, a $150M undrawn revolver, and a 42.1% ROE. Operating cash flow of $207M comfortably funded $36.3M of capex (up 19.7% as management invests in capacity, sustainability and efficiency). The $133M cash drawdown and the 20.6% equity decline are not stress — they reflect the $304M special dividend paid in Q1, a deliberate capital-return choice by the Caporella-controlled board, not a deterioration.
Is FIZZ a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | $1.14B | $1.17B | $1.19B | $1.20B | $1.18B |
| Gross profit | $418M | $397M | $428M | $444M | $437M |
| Operating income | $208M | $187M | $219M | $235M | $230M |
| Net income | $159M | $142M | $177M | $187M | $184M |
| Diluted EPS | $1.69 | $1.52 | $1.89 | $1.99 | $1.96 |
| Net margin | 13.9% | 12.1% | 14.8% | 15.6% | 15.6% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0000069891, latest 10-K filed 2026-07-01) · EODHD · Proprietary analysis · as of 6/25/2026, 1:49:53 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:49 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2025-04-15 | sheridan stanley michael Director | Sell | 8.00K @ $43.40 | $347K |
| 2024-12-31 | sheridan stanley michael Director | Sell | 6.10K @ $42.49 | $259K |
| 2024-12-30 | HATHORN SAMUEL C Director | Gift | 20.0K @ $42.50 | $850K |
| 2024-12-13 | CONLEE CECIL D Director | Sell | 5.26K @ $46.76 | $246K |
| 2024-12-12 | CONLEE CECIL D Director | Sell | 2.74K @ $47.01 | $129K |
| 2024-07-11 | CONLEE CECIL D Director | Sell | 10.0K @ $50.11 | $501K |
| 2024-07-05 | sheridan stanley michael Director | Sell | 16.0K @ $51.81 | $829K |
| 2024-06-13 | CONLEE CECIL D Director | Exercise | 6.00K @ $0.01 | $60.00 |
| 2024-04-09 | CONLEE CECIL D Director | Sell | 12.0K @ $47.94 | $575K |
| 2023-12-26 | HATHORN SAMUEL C Director | Gift | 2.00K @ $49.80 | $99.6K |
| 2023-12-22 | HATHORN SAMUEL C Director | Gift | 6.00K @ $49.34 | $296K |
| Renaissance Technologies | 2.95M sh | $99.1M |
As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.